Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.

The challenge, open from May 7 to June 7, invites school and university students to design a poster that answers the question ...

KalVista Pharmaceuticals, Inc. today announced that it will present new sebetralstat data at two upcoming congresses taking place concurrently from May 29?June 1, 2025: the 14th C1-inhibitor ...